-
Most Popular
Search Results
240 results for fsa
Trade of the Day: SU Stock Could Shine in Beaten-Down Sector
Suncor Energy Inc. USA may be putting in a bottom.
Lorillard Shares Keep Smoking
An FDA ruling has this tobacco stock flying high.
FDA’s Easing on Obesity Drugs Could Fatten Investor Wallets
Vivus and Orexigen’s diet-pill hopes are resurrected as the FDA relaxes its stance against obesity treatments.
XXII Stock Alert: Why Is 22nd Century Group Soaring Higher Today?
Agricultural biotech company 22nd Century Group is celebrating an FDA designation. As a result, XXII stock is up 40% today.
FSR Stock Alert: Fisker Delivers 100 Vehicles a Day With New Strategy
Fisker has adopted a new distribution strategy that is positive for FSR stock. But demand remains the key issue for this EV startup.
FSI Stock: The Hidden Gem of the Green Wave Revolution
Although risky and under-the-radar, if it successfully capitalizes on green trends, FSI stock could really take off in price over time.
5 Biotech Stocks With Big Catalysts on the Horizon
Announcements from, or about, these biotech stocks could greatly inflate their values … or completely deflate them.
FDA Lists 16 Dog Foods Linked to Canine Heart Disease
The U.S. Food & Drug Administration (FDA) has released a list of dog foods linked to canine heart disease in a new report.
3 Stocks to Watch on Monday: Amazon.com, Inc. (AMZN), CSX Corporation (CSX) and Humana Inc (HUM)
Amazon (AMZN) could face probe over Prime delivery times, CSX’s (CSX) CEO died over the weekend and Humana (HUM) is in talks to buy Kindred…
Why Is Kaival Brands (KAVL) Stock Soaring 20% Today?
Kaival Brands was handed a disappointing ruling from the FDA, but KAVL stock is moving higher after a new appeals-court decision.
We’re Getting Closer to Legitimate Drone Stocks
The FAA has been granting drone companies approval for commercial use, but not many drone stocks are on the list.
Top 50 Spots to Celebrate New Year’s Eve
Priceline.com has compiled a list of the 50 top places to ring in 2013, with New York City topping the list for the second consecutive…
The Same Problems Persist for Ocugen in Marketing Covaxin
OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward long term.
Inovio Pharmaceutical’s FDA Plight Makes It a Highly Risky Bet
INO stock has tumbled in the past few months. Inovio needs the FDA to bail it out by allowing the advanced trials of its vaccine…
Why Ocugen Stock Continues to Be a Great Short Opportunity
No U.S. government official has made positive comments about approving Covaxin and the Covaxin trials do not seem to meet the FDA’s preferences. OCGN stock…
If You Want to Participate in the FSR Stock Lawsuit, Mark Your Calendars for Jan. 26
FSR stock is trending close to its lowest level ever as a class action against the EV maker gains traction.
Here’s a Top REIT to Buy for High Yield
When stocks turn up that see insider buying and are also top-ranked — like Franklin Street Properties Corp. (NYSEMKT:FSP) — investors are wise to take…
Fisker Stock Seems to Have Bottomed Out and Could Recover Long Term
Fisker is ready for production later this year and its EV looks amazing. FSR stock belongs on long-term portfolios.
Buy FSI Stock Despite ‘Disappointing’ Q2 Earnings. Here’s Why.
Despite missing on revenue and earnings last quarter, FSI stock (while risky) remains a high-potential “green wave” play.
For Now, Amarin Stock Is a Gamble on FDA Approval
Although Amarin stock could potentially skyrocket off the pharmaceutical’s flagship drug Vascepa, approval challenges make this play incredibly risky.
6 – 10 of 240 results
